Latest In: drugs

From Big Pharma to the cannabis industry: Q&A with PharmaCann’s Chris Diorio

PharmaCann's Chris Diorio talks about his move to work at a cannabis company, his perceptions of the MJ…

News March 28

President Donald Trump in the Oval Office signing an executive order reclassifying cannabis as less dangerous.

Trump marijuana rescheduling is ‘solely’ political, opponent claims as DEA hearings begin

Photo of electric power meters on red electrical panels

How cannabis cultivators are responding to rising energy costs

Second US cannabis company uplisted to NYSE to begin trading Tuesday

Image of DEA agent badge

Why cannabis businesses need to apply for DEA registration now – and why states must help

Image of a partially open bank vault door with a glowing light emanating from within

Bipartisan lawmakers reintroduce SAFER Banking on eve of marijuana rescheduling hearings

1

Patient attending an online medical cannabis education consultation with a licensed practitioner.

The Next Competitive Advantage in Medical Cannabis Is Clarity

Image of a "For Lease" sign in front of a vacant business space

Green Life Business Group brokers the cannabis industry’s biggest deals

The New Genetics Race: Why Cannabis Seed Brands Are Becoming the Next Big Differentiator

The Medical Card Has a New Argument

Leveling the Legal Playing Field